Overview

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

Status:
RECRUITING
Trial end date:
2027-09-20
Target enrollment:
Participant gender:
Summary
The goal of this study is to assess the safety and tolerability of GSK5733584. The study will also see how the levels of GSK5733584 change over time at different dose amount.
Phase:
PHASE1
Details
Lead Sponsor:
GlaxoSmithKline